Pages that link to "Q71529333"

The following pages link to Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO (Q71529333):

Displaying 40 items.

• Obesity and PCOS: implications for diagnosis and treatment (Q27000954) (← links)
• Which hormone tests for the diagnosis of polycystic ovary syndrome? (Q28205978) (← links)
• Alpha-fetoprotein, the major fetal serum protein, is not essential for embryonic development but is required for female fertility. (Q28509411) (← links)
• Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications (Q33569169) (← links)
• Effects of a pure antiandrogen on gonadotropin secretion in normal women and in polycystic ovarian disease (Q34534835) (← links)
• The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms (Q35349649) (← links)
• Serum lipids and memory in a population based cohort of middle age women (Q35470847) (← links)
• The serum steroid transport proteins: Biochemistry and clinical significance (Q40079659) (← links)
• Polycystic ovarian disease as a neuroendocrine disorder of the female reproductive axis. (Q40708585) (← links)
• Polycystic ovary syndrome: current and future treatment paradigms (Q40831696) (← links)
• Neuroendocrinology of the polycystic ovary syndrome (Q41084847) (← links)
• Evidence for altered catecholamine metabolism in polycystic ovary syndrome (Q41573220) (← links)
• Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors (Q41706724) (← links)
• Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia? (Q42114421) (← links)
• Analysis of gonadotropin pulsatility in hirsute women with normal menstrual cycles and in women with polycystic ovary syndrome (Q42470579) (← links)
• Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease. (Q42623831) (← links)
• Polycystic ovarian disease: Endocrinological parameters with specific reference to growth hormone and somatomedin-C (Q43440780) (← links)
• Alterations in androgen conjugate levels in women and men with alopecia. (Q43585574) (← links)
• Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries (Q43837581) (← links)
• The ratio of androstenedione: 11β-hydroxyandrostenedione is an important marker of adrenal androgen excess in women (Q45188124) (← links)
• Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome (Q48326902) (← links)
• Introduction and history of polycystic ovary syndrome (Q62026014) (← links)
• Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women (Q67898905) (← links)
• Hirsutism (Q68170295) (← links)
• Determination of serum delta 5-3 beta-hydroxysteroid sulphates by combined high-performance liquid chromatography and immobilized 3 beta,17 beta-hydroxysteroid dehydrogenase in column form (Q69994891) (← links)
• The control of bioactive luteinizing hormone secretion in women with polycystic ovary syndrome (Q70320051) (← links)
• Effect of androgen excess on inappropriate gonadotropin secretion as found in the polycystic ovary syndrome (Q70565384) (← links)
• Clinical and laboratory predictors of clomiphene response (Q70673700) (← links)
• Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease (Q70798349) (← links)
• Androgens and prolactin levels in hirsute women with either polycystic ovaries or "borderline ovaries" (Q71453773) (← links)
• An extended regimen of clomiphene citrate in women unresponsive to standard therapy (Q72756116) (← links)
• Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome (Q72782118) (← links)
• Obesity, serum steroid levels, and pulsatile gonadotropin secretion in polycystic ovarian disease (Q72792243) (← links)
• A randomized study of dexamethasone in ovulation induction with clomiphene citrate (Q72815154) (← links)
• Immunohistochemical localization of renin and angiotensin in the ovary: comparison between normal women and patients with histologically proven polycystic ovarian disease (Q72853216) (← links)
• The prognostic value of acute adrenal suppression and stimulation tests in hyperandrogenic women (Q72923112) (← links)
• Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome1 (Q73493513) (← links)
• Stress promotes development of ovarian cysts in rats: the possible role of sympathetic nerve activation (Q77314179) (← links)
• Bone mineral density and body composition in lean women with polycystic ovary syndrome (Q78067120) (← links)
• Prolactin pulsatility in polycystic ovarian disease (Q93609757) (← links)